SCHEMBL19106990

SCHEMBL19106990

COc1cc(C)cc(/C=C/I)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 10/20 0.56
CYP1B1 Q16678 10/20 0.56
CYP1A2 P05177 6/20 0.47
NQO2 P16083 5/20 0.47
TTR P02766 4/20 0.47
ABL1 P00519 3/20 0.47
BCR P11274 3/20 0.47
ALOX5 P09917 3/20 0.47
PTGS2 P35354 3/20 0.47
ESR1 P03372 2/20 0.47
ABCB1 P08183 2/20 0.47
CYP19A1 P11511 2/20 0.47
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
AHR P35869 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12729845 1.00 CYP1A1 (0.56) CYP1A1CYP1B1CYP1A2NQO2TTR
SCHEMBL5447309 0.87 CYP1A1 (0.73) CYP1A1CYP1B1CYP1A2NQO2TTR
SCHEMBL16362233 0.85 CYP1A1 (0.77) CYP1A1CYP1B1CYP1A2NQO2TTR
SCHEMBL13369584 0.82 CYP1A1 (0.58) CYP1A1CYP1B1CYP1A2NQO2TTR
SCHEMBL12729847 0.80 CYP1A1 (0.65) CYP1A1CYP1B1CYP1A2NQO2TTR
SCHEMBL10312395 0.78 RELA (0.68) CYP1A1CYP1B1CYP1A2NQO2TTR
SCHEMBL12535856 0.78 PTGS2 (0.78) CYP1A1CYP1B1CYP1A2NQO2TTR
SCHEMBL19187093 0.78 THRB (0.59) CYP1A1CYP1B1CYP1A2PTGS2KDM4E
SCHEMBL11999776 0.78 F3 (0.56) CYP1A1CYP1B1CYP1A2NQO2TTR
SCHEMBL12729855 0.77 KDM4E (0.69) CYP1A1CYP1B1CYP1A2NQO2TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342047-A1 Cancerous Cell Growth Inhibiting Compounds WISYS TECHNOLOGY FOUNDATION, INC. 2017-11-30 US disclosed
US-20170197897-A1 Skin Lightening Compounds WISYS TECH FOUND INC (US) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342047-A1 Cancerous Cell Growth Inhibiting Compounds TYR, MKI67, MC1R CYP1A1 226/4885CYP1B1 56/4885CYP1A2 329/4885
US-20170197897-A1 Skin Lightening Compounds TYR, MC1R, MCHR1 CYP1A1 75/4885CYP1B1 49/4885CYP1A2 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.